FTC Interim Report on Pharmacy Middlemen Is First Step of Many Needed in Addressing Drug Costs, AccessAugust 15, 2024Business of Medicine
Study Identifies Oral Antibiotics Linked to Severe Cutaneous ReactionsAugust 12, 2024PediatricsMixed Topics
FDA Approves Lymphir for R/R Cutaneous T-Cell LymphomaAugust 9, 2024T Cell LymphomasPatient & Survivor CareBusiness of Medicine
Immunotherapy May Be Overused in Dying Patients With CancerAugust 8, 2024DLBCLMixed TopicsPatient & Survivor CarePediatricsAggressive LymphomasALLAML
FDA Approves First Engineered Cell Therapy for a Solid TumorAugust 2, 2024Patient & Survivor CareBusiness of Medicine
FDA Expands Darzalex Faspro Indication in MyelomaAugust 2, 2024Multiple MyelomaPatient & Survivor CareBusiness of Medicine
The Last 30 Days: How Oncologists’ Choices Affect End-of-Life Cancer CareAugust 2, 2024Patient & Survivor CareDLBCLMixed Topics
Ancient Viruses in Our DNA Hold Clues to Cancer TreatmentAugust 2, 2024Patient & Survivor CareDLBCLMixed TopicsAggressive LymphomasALLAMLB Cell Lymphoma
